Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study

Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study

Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder with significant metabolic implications, including an increased risk of cardiovascular diseases and diabetes. Kallistatin, a serine proteinase inhibitor with anti-inflammatory and antioxidative properties, has been identi...

Full description

Bibliographic Details
Main Authors: Aslihan Yurtkal, Mujde Canday
Format: Article
Language:English
Published: MDPI AG 2024-07-01
Series:Diagnostics
Subjects:
diagnostic biomarker
hyperandrogenism
inflammation
kallistatin
oxidative stress
polycystic ovary syndrome
Online Access:https://www.mdpi.com/2075-4418/14/14/1553

Internet

https://www.mdpi.com/2075-4418/14/14/1553

Similar Items